Literature DB >> 7534891

Decrease and increase of responses to glutamate receptor agonists in RNA-injected Xenopus oocytes by the epileptogenic agent pentylenetetrazol: dependence on the agonist concentration.

P Bloms-Funke1, U Musshoff, M Madeja, F Spener, E J Speckmann.   

Abstract

The effects of the epileptogenic agent pentylenetetrazol (PTZ) on current responses to glutamate (Glu) and to the Glu receptor agonist N-methyl-D-aspartate (NMDA), kainate (KA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and quisqualate (QA) were studied on RNA-injected Xenopus oocytes. PTZ antagonized the reactions to Glu as well as to NMDA, KA, AMPA and QA. With increasing concentration of AMPA, however, the depressive effect of PTZ turned to an augmentation. The complete change from a decreasing to an increasing effect of PTZ with elevated agonist concentration was unique for current responses by AMPA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534891     DOI: 10.1016/0304-3940(94)90584-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Blockade of glutamatergic and GABAergic receptor channels by trimethyltin chloride.

Authors:  Katharina Krüger; Victoria Diepgrond; Maria Ahnefeld; Christina Wackerbeck; Michael Madeja; Norbert Binding; Ulrich Musshoff
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Study of epileptiform activity in cerebral ganglion of mud crab Scylla serrata.

Authors:  K K Therisa; P V Desai
Journal:  Invert Neurosci       Date:  2011-01-20

3.  Aconitine inhibits epileptiform activity in rat hippocampal slices.

Authors:  A Ameri; J Gleitz; T Peters
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

4.  Activation of ATP-sensitive potassium channels in follicle-enclosed xenopus oocytes by the epileptogenic agent pentylenetetrazol.

Authors:  N Klöcker; U Musshoff; M Madeja; E J Speckmann
Journal:  Pflugers Arch       Date:  1996-03       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.